𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical reactivation during lamivudine treatment correlates with mutations in the precore/core promoter and polymerase regions of hepatitis B virus in patients with anti-hepatitis B e-positive chronic hepatitis

✍ Scribed by A. MARRONE; R. ZAMPINO; P. KARAYANNIS; G. CIRILLO; G. CESARO; B. GUERRERA; R. RICCIOTTI; E. MIRAGLIA DEL GIUDICE; R. UTILI; L. E. ADINOLFI; G. RUGGIERO


Book ID
108604261
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
281 KB
Volume
22
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Precore/core promoter mutations and geno
✍ Chun-Jen Liu; Jia-Horng Kao; Ming-Yang Lai; Pei-Jer Chen; Ding-Shinn Chen 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 2 views

## Abstract The association of precore stop codon mutation (A1896), dinucleotide mutation (T1762/A1764) in the basic core promoter of hepatitis B virus (HBV) genome, and genotype of HBV with fulminant or subfulminant hepatitis remains controversial. We studied HBV genotypes as well as mutations in

Efficacy of lamivudine in patients with
✍ Nicolaos C. Tassopoulos; Riccardo Volpes; Giuseppe Pastore; Jenny Heathcote; Mar 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 1 views

This placebo controlled, double-blind study evaluated the efficacy and safety of lamivudine in patients with hepatitis B e antigen (HBeAg)-negative/hepatitis B virus (HBV) DNA-positive chronic hepatitis B. Patients were randomized to receive 100 mg lamivudine orally once daily for 52 weeks (n ‫؍‬ 60

Low frequency of precore hepatitis B vir
✍ Marie Anne Loriot; Patrick Marcellin; Nathalie Talbodec; Véronique Guigonis; Mic 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 611 KB

The objective of this study was to evaluate the role of hepatitis B virus (HBV) precore mutations in patients with anti-me-positive chronic hepatitis B with or without previous known HBe antigen (HBeAg) viremic phase, and to assess the potential implication of precore mutants in HBeAg-negative react

Mutations in the core promoter region of
✍ Kurosaki, Masayuki; Enomoto, Nobuyuki; Asahina, Yasuhiro; Sakuma, Ikuo; Ikeda, T 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 869 KB

The core promoter region of hepatitis B virus genomes regulates transcription of the precore and pregenomic mRNAs encoding hepatitis B e antigen (HBeAg) and core antigen that contain target epitopes for cytotoxic T lymphocytes. The prevalence and clinical significance of mutations in this region wer

Different hepatitis b virus genotypes ar
✍ Henry L. Y. Chan; Munira Hussain; Anna S. F. Lok 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB

Mutations in the core promoter and precore regions are frequently found in hepatitis B e antigen (HBeAg)-negative patients, but precore stop codon mutation is restricted to hepatitis B virus (HBV) genotypes that have T at nucleotide 1858. The aims of this study were to determine the role of core pro